RUNX3 and cancer: The model trajectories were explored to identify the paths involved in the overexpression of DNMT1, activation of oncogene (c-myc), and suppression of tumor suppressor genes (RUNX3, p21, and p53) leading to cancer invasion or recovery (homeostasis).